April 26 (Reuters) - SMCP SA SMCP.PA :
* 2022 Q1 SALES
* Q1 SALES ROSE 26.4 PERCENT TO 283 MILLION EUR
* RECENT COVID RESTRICTIONS HAD A SIGNIFICANT IMPACT ON
SALES,
FIRST IN HONG-KONG AND LATER IN MAINLAND CHINA
* SMCP IS CLOSELY MONITORING THE HEALTH CONTEXT IN APAC AND
THE
IMPACT OF THE RESTRICTIONS ON THE IN-STORE TRAFFIC AS WELL AS ON
SUPPLY CHAIN CAPABILITIES
* REMAINS CAUTIOUS AS THE SITUATION IN MAINLAND CHINA CAN
EVOLVE
RAPIDLY AND NEW CITIES COULD BE IMPACTED
* CONFIRMS ITS FINANCIAL GUIDANCE FOR 2022 PROVIDED THAT THE
HEALTH CONTEXT IN APAC IMPROVES FAIRLY RAPIDLY
* Q1 SALES UP +24% DRIVEN BY LFL, THANKS TO STRONG LOCAL
DEMAND
* AS A REMINDER, FOR FULL YEAR 2022, SMCP ANTICIPATES SOLID
DOUBLE-DIGIT SALES GROWTH VERSUS 2021 AND MIDSINGLE-DIGIT SALES
GROWTH VERSUS 2019
* REGARDING PROFITABILITY, THE GROUP EXPECTS AN ADJUSTED
EBIT
MARGIN (AS A % OF SALES) IN LINE WITH 2021 IN A CONTEXT OF
SIGNIFICANT INFLATION
* Q1 SALES AT EUR 283.0M, UP +23.7% ON AN ORGANIC BASIS
VERSUS
2021
* SMCP THUS ANTICIPATES A NET DEBT LEVERAGE RATIO OF <2X AT
THE
END OF 2022 (INSTEAD OF END OF 2023)
Source text for Eikon: ID:nGNE58ZmqZ
Further company coverage: SMCP.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))